A Novel Variant in G6PD (c.1375C>G) Identified from a Hispanic Neonate with Extreme Hyperbilirubinemia and Low G6PD Enzymatic Activity

Neonatology. 2020;117(4):532-535. doi: 10.1159/000510300. Epub 2020 Sep 28.

Abstract

We report a novel glucose-6-phosphate dehydrogenase (G6PD) variant (c.1375C>G) discovered in a 3-day-old Hispanic male child from Salt Lake City, UT, USA. This newborn presented with severe hyperbilirubinemia (29.8 mg/dL or 510 μmol/L) and marked hemolysis evidenced by elevated end-tidal carbon monoxide concentration (5.9 ppm, normal <1.7 ppm). Despite a very low prevalence of G6PD deficiency in Hispanic populations, we pursued testing for this condition and found he had low erythrocyte G6PD enzyme activity (2.8 U/g Hb, normal 9.9-16.6 U/g Hb) and a novel G6PD variant. His mother was heterozygous for this same variant, and she had a moderate decrease in G6PD enzyme activity (7.1 U/g Hb). On the basis of these findings, we propose this variant as a novel pathogenic mutation.

Keywords: Glucose-6-phosphatase deficiency; Hemolysis; Hyperbilirubinemia; Next-generation sequencing; Novel variant.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Glucosephosphate Dehydrogenase Deficiency* / genetics
  • Glucosephosphate Dehydrogenase* / genetics
  • Heterozygote
  • Hispanic or Latino / genetics
  • Humans
  • Hyperbilirubinemia* / genetics
  • Infant, Newborn
  • Male

Substances

  • Glucosephosphate Dehydrogenase